For tumors lacking sufficient cGAS or STING, such as melanoma, colorectal and alternative lengthening of telomeres (ALT)-related cancer, targeting the cGAS-STING pathway for antitumor therapy may not be feasible, and oncolytic virus treatment might represent an alternative approach [161]. Here, STING1 is linked to cancer.